Novel ligand antagonists of the RAR receptors have the following structural formula (I): ##STR00001## in which A is a CH.sub.2, CHOH, C.dbd.O or C.dbd.N--OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): ##STR00002## and Ar is a radical selected from among those of formulae (g) to (i): ##STR00003##

 
Web www.patentalert.com

< System and method for regulating cardiopulmonary triggered therapy to the brain

> Dipeptidyl peptidase inhibitors

> Azolo triazines and pyrimidines

~ 00544